跳至主要内容
临床试验/NCT04828317
NCT04828317Unknown不适用

Placebo Controlled Alpha-gal Pork Challenge

University of Virginia0 个研究点目标入组 54 人开始时间: 2021年5月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
54
主要终点
Composite GI symptom score

研究概览

简要总结

This study is investigating the hypothesis that alpha-gal is responsible for the gastrointestinal symptoms that occur in some alpha-gal syndrome subjects following the consumption of mammalian meat. This will be tested by comparing symptoms and immune responses in subjects with alpha-gal syndrome following consumption of "wild-type" pork (which contains alpha-gal) versus consumption of a novel pork product which has been genetically modified to lack alpha-gal (GalSafe pork from Revivicor Inc.).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Alpha-gal cases:
  • Age 18-70
  • Patient report of episodic GI symptoms within past 6 months that correlated with ingestion of mammalian meat and/or dairy and which improved on a mammalian avoidance diet.
  • IgE to α-Gal >0.1 IU/mL at screening visit.
  • Willingness and ability to comply with scheduled visits and study procedures.
  • Control subjects:
  • Age 18-70
  • Regularly consume/tolerate mammalian meat without obvious associated gastrointestinal or skin symptoms.
  • Have eaten mammalian meat within the past 2 weeks
  • Willingness and ability to comply with scheduled visits and study procedures.

排除标准

  • Alpha-gal cases:
  • History of anaphylaxis that was or could have been attributed to mammalian meat in the estimation of the PI.
  • IgE to pork which exceeds the value of IgE to α-Gal on screening test
  • Unexplained, persistent urticaria or pruritis.
  • Pregnancy, breastfeeding or lack of birth control in women of child-bearing age.
  • At the discretion of the principal investigator, patients may be excluded due to poorly controlled chronic gastrointestinal conditions including but not limited inflammatory bowel disease (i.e., Crohn's disease, ulcerative colitis, microscopic colitis), acid reflux/heartburn, history of bariatric surgery or gastric banding, active peptic ulcer disease or any abdominal surgery within the past 2 months.
  • Patient is unable to swallow food or has poor peripheral access.
  • Patient has any medical or physiological disorder or condition that, in the opinion of the Investigator, would compromise the well-being of the patient or study or prevent the patient from meeting or performing study requirements.
  • Control subjects:
  • History of anaphylaxis that was or could have been attributed to mammalian meat in the estimation of the PI
  • Unexplained, persistent urticaria or pruritis.
  • Poorly controlled chronic gastrointestinal problem
  • Patient is unable to swallow food or has poor peripheral access
  • Patient has any medical or physiological disorder or condition that, in the opinion of the Investigator, would compromise the well-being of the patient or study or prevent the patient from meeting or performing study requirements.

结局指标

主要结局

Composite GI symptom score

时间窗: Score is calculated from survey of gastrointestinal symptoms between 1 and 5 hours after challenge. .

GI symptoms will be assessed using modified FAST diary. Score is determined from a survey of five gastrointestinal symptoms obtained at 0,1,3,5 hours following oral pork challenge. Symptoms are measured via numerical rating scale (1-5) and aggregate score will be calculated.

次要结局

  • Tryptase(Serial samples from 0 to 5 hours post-challenge)
  • Histamine/Methyl-histamine(Serial samples from 0 to 6 hours post-challenge)
  • 11Beta-PGF2-alpha(Serial samples from 0 to 6 hours post-challenge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeffrey Wilson, MD

Assistant Professor of Medicine

University of Virginia

相似试验